Pande Atul bought IMVT
April 7, 2026 · Form 4 insider transaction
Pande Atul bought 13,880 shares of Immunovant, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
13,880
Price
$0.00
Total value
N/A
InsiderPande Atul
Role—
CompanyImmunovant, Inc. (IMVT)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateApril 7, 2026
Filing dateApril 9, 2026
Shares owned after116,731
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.